+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Atrial Fibrillation Surgery Market - Global Forecast 2026-2032- Product Image
Atrial Fibrillation Surgery Market - Global Forecast 2026-2032- Product Image
Sale

Atrial Fibrillation Surgery Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904628
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Atrial Fibrillation Surgery Market is projected to reach USD 3.43 Billion in 2026. It is expected to continue growing at a CAGR of 9.56%, reaching USD 5.98 Billion by 2032.

Atrial fibrillation surgery is moving from a niche cardiac procedure category to a strategic growth area within electrophysiology and structural heart care. Atrial fibrillation is the most common sustained cardiac arrhythmia, and the Global Burden of Disease study estimated that more than 59 million people were living with atrial fibrillation or atrial flutter in 2019. Rising age, hypertension, obesity, diabetes, sleep apnea, and heart failure are expanding the eligible patient pool and increasing demand for durable rhythm-control interventions.

The atrial fibrillation surgery market includes Cox-Maze IV surgical ablation, minimally invasive thoracoscopic ablation, hybrid epicardial-endocardial procedures, concomitant ablation during valve or coronary artery bypass surgery, and left atrial appendage management. Demand is strongest where cardiac surgery, electrophysiology, advanced imaging, perioperative stroke prevention, and outcomes-based reimbursement intersect.

Transformative Shifts in the Atrial Fibrillation Surgery Landscape

The landscape is shifting from open cut-and-sew surgery toward energy-based lesion creation, minimally invasive access, hybrid ablation pathways, and integrated rhythm-care programs. Modern radiofrequency and cryoablation platforms have improved procedural consistency, while multidisciplinary heart teams are expanding treatment options for persistent and long-standing persistent atrial fibrillation, particularly in patients already undergoing cardiac surgery.

Clinical guidance is also shaping adoption. The 2023 ACC/AHA/ACCP/HRS atrial fibrillation guideline supports surgical ablation during selected cardiac surgeries and emphasizes stroke-risk reduction strategies, including left atrial appendage management in appropriate patients. At the same time, remote monitoring, implantable loop recorders, and digital follow-up are improving recurrence detection and creating stronger evidence for durable rhythm control, patient selection, and post-operative care pathways.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a compounding force across the atrial fibrillation surgery value chain. AI-enabled ECG interpretation, imaging segmentation, and risk stratification can help identify patients who may benefit from earlier rhythm-control intervention, while predictive models support decisions around ablation strategy, left atrial size, fibrosis burden, anticoagulation needs, and recurrence risk.

In the operating room and hybrid lab, AI is expected to improve workflow planning, lesion assessment, mapping integration, and quality assurance. Post-procedure, machine learning can analyze wearable and remote-monitoring data to detect recurrence faster than episodic follow-up. The greatest near-term value will come from validated clinical decision support, transparent algorithms, cybersecurity, clinician oversight, and compliance with medical-device regulations.

Key Regional Insights

Asia-Pacific is positioned for strong long-term demand because of population scale, rapid aging, and rising cardiovascular risk in China, India, Japan, South Korea, and Australia. Japan and Australia benefit from mature cardiac surgery infrastructure, established specialist referral systems, and advanced electrophysiology capabilities, while China and India are expanding tertiary cardiac centers and rhythm-care capacity, supporting broader access to surgical ablation, hybrid procedures, and left atrial appendage management.

North America remains a leading innovation and adoption region, supported by advanced hospital networks, specialist electrophysiology programs, FDA-regulated device pathways, high use of remote monitoring, and strong implementation of evidence-based guidelines. Europe benefits from high procedural expertise, national cardiac registries, and harmonized clinical practice under European professional societies, with adoption supported by structured cardiac care pathways and outcomes reporting. Latin America, led by Brazil and Mexico, is expanding access through major urban cardiac centers, although reimbursement consistency, specialist availability, and advanced device access vary across health systems. The Middle East is gaining momentum through GCC investments in tertiary hospitals, cardiovascular centers, and medical technology adoption, while Africa remains underpenetrated due to limited cardiac surgery capacity, uneven access to rhythm-care diagnostics, and shortages of trained electrophysiology and cardiothoracic surgery teams.

Key Group Insights

ASEAN markets are advancing through hospital modernization, medical tourism, and growing electrophysiology training, with Singapore, Thailand, and Malaysia serving as regional procedure hubs for complex cardiovascular care. The GCC is investing in high-acuity cardiovascular services, tertiary hospitals, and specialist workforce development, creating opportunities for premium surgical ablation systems, hybrid operating rooms, and partnerships with international centers of excellence.

The European Union offers scale through standardized regulatory expectations, strong clinical networks, and adoption of guideline-driven care, although EU Medical Device Regulation requirements have increased evidence, post-market surveillance, and compliance burdens for manufacturers. BRICS countries represent high-volume potential because of large atrial fibrillation populations, aging demographics, and expanding tertiary care, but pricing, procurement, training, and access strategies must be localized. G7 markets remain the benchmark for innovation, reimbursement evidence, clinical trial activity, and premium device adoption, while NATO-aligned health systems increasingly emphasize supply resilience, interoperability, cybersecurity, and trusted clinical technologies for critical cardiovascular care.

Key Country Insights

The United States is the most commercially advanced market for atrial fibrillation surgery, supported by high atrial fibrillation prevalence, specialized electrophysiology programs, Medicare coverage pathways, advanced imaging, and strong uptake of minimally invasive and hybrid cardiac procedures. Canada shows steady adoption through publicly funded cardiac centers and evidence-based referral pathways, while Mexico and Brazil are expanding access in large metropolitan hospitals where private and public cardiovascular centers are investing in advanced rhythm-care capabilities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from established cardiac surgery networks, guideline-based rhythm management, and growing use of multidisciplinary atrial fibrillation programs, with Germany standing out for procedural capacity, hospital density, and device evaluation infrastructure. Russia has a sizable cardiovascular burden but faces procurement, access, and technology availability constraints that can affect adoption consistency. China and India offer the largest long-term volume opportunity as tertiary hospitals scale advanced rhythm care, cardiothoracic surgery, and electrophysiology services for large patient populations. Japan and South Korea combine aging demographics with high technology adoption, advanced hospital infrastructure, and strong clinical expertise, while Australia maintains robust outcomes infrastructure, specialist access across major urban centers, and established use of guideline-directed cardiovascular care.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize integrated atrial fibrillation programs that connect cardiac surgeons, electrophysiologists, imaging specialists, stroke-prevention teams, anesthesiology, and digital monitoring platforms. Organizations that demonstrate durable sinus rhythm, lower stroke risk, fewer repeat interventions, reduced complications, and improved quality of life will be better positioned in value-based procurement environments.

Strategic actions include investing in physician training for hybrid ablation, building real-world evidence registries, designing devices for reproducible transmural lesion creation, and aligning AI tools with regulatory-grade validation. Manufacturers should localize pricing, training, service, and maintenance models for emerging markets, while hospitals should track recurrence, complications, length of stay, readmissions, anticoagulation outcomes, and patient-reported quality-of-life measures to strengthen reimbursement discussions and improve patient selection.

Research Methodology

The research approach applies secondary and primary intelligence methods aligned with established industry research standards. Inputs include peer-reviewed cardiology and cardiothoracic surgery literature, professional society guidelines, public health databases, regulatory documents, hospital purchasing patterns, procedure pathway assessments, and device approval information.

Findings are triangulated across clinical evidence, epidemiology, reimbursement conditions, installed procedure capacity, regulatory status, physician adoption patterns, and regional access dynamics. Interpretation emphasizes verified, data-backed indicators such as atrial fibrillation prevalence, cardiac surgery volumes, technology adoption, guideline recommendations, safety outcomes, and real-world evidence. Qualitative insights are validated through expert review and cross-comparison to avoid unsupported claims, market sizing, or speculative forecasting.

Conclusion

Atrial fibrillation surgery is set to remain a high-value segment of cardiovascular care as disease prevalence rises and evidence supports earlier, more integrated rhythm-control strategies. Clinical adoption will be shaped by minimally invasive surgical ablation, hybrid procedures, concomitant ablation during cardiac surgery, left atrial appendage management, digital monitoring, and AI-enabled patient selection.

The most successful organizations will combine clinical rigor with operational scalability. Markets with strong specialist networks, reimbursement clarity, regulatory preparedness, and outcomes tracking will lead adoption, while emerging regions will require affordability, training, infrastructure investment, and reliable follow-up systems. Across all regions, durable outcomes, validated evidence, and multidisciplinary care delivery will define competitive advantage in atrial fibrillation surgery.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Atrial Fibrillation Surgery Market, by Procedure Type
7.1. Introduction
7.2. Catheter Ablation
7.3. Hybrid Ablation
7.4. Surgical Maze
8. Atrial Fibrillation Surgery Market, by Energy Source
8.1. Introduction
8.2. Cryoablation
8.3. Laser
8.3.1. Excimer Laser
8.3.2. Holmium Laser
8.4. Radiofrequency
8.5. Ultrasound
8.5.1. High-Intensity Focused Ultrasound
8.5.2. Intravascular Ultrasound
9. Atrial Fibrillation Surgery Market, by Indication
9.1. Introduction
9.2. Paroxysmal
9.3. Permanent
9.4. Persistent
9.4.1. Long-Standing Persistent
9.4.2. Short-Term Persistent
10. Atrial Fibrillation Surgery Market, by Surgical Approach
10.1. Introduction
10.2. Open-Heart Surgery
10.3. Minimally Invasive Surgery
11. Atrial Fibrillation Surgery Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Cardiac Centers
12. Atrial Fibrillation Surgery Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Atrial Fibrillation Surgery Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Atrial Fibrillation Surgery Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Acutus Medical, Inc
16.3. Affera, Inc.
16.4. AFreeze GmbH
16.5. Atrian Medical Ltd.
16.6. AtriCure, Inc.
16.7. AuriGen Medical
16.8. BIOTRONIK SE & CO. KG
16.9. Boston Scientific Corporation
16.10. Cardiofocus, Inc.
16.11. CathRx Ltd
16.12. Cook Group Incorporated
16.13. F. Hoffmann-La Roche AG
16.14. GE HealthCare Technologies Inc.
16.15. Healium Medical
16.16. Japan Lifeline Co.
16.17. Johnson & Johnson Services, Inc.
16.18. Kardium Inc.
16.19. Koninklijke Philips N.V.
16.20. Medtronic PLC
16.21. Osypka AG
16.22. SentiAR, Inc
16.23. Siemens Healthcare GmbH
16.24. Stryker Corporation
16.25. Terumo Corporation
16.26. Toray Medical Co., Ltd.
16.27. Vanguard AG
16.28. Volta Medical
List of Figures
FIGURE 1. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CATHETER ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CATHETER ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CATHETER ABLATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL HYBRID ABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL HYBRID ABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL HYBRID ABLATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SURGICAL MAZE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SURGICAL MAZE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SURGICAL MAZE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CRYOABLATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CRYOABLATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CRYOABLATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL LASER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL LASER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL LASER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL EXCIMER LASER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL EXCIMER LASER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL EXCIMER LASER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL HOLMIUM LASER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL HOLMIUM LASER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL HOLMIUM LASER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL RADIOFREQUENCY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL RADIOFREQUENCY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL RADIOFREQUENCY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL HIGH-INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL HIGH-INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL HIGH-INTENSITY FOCUSED ULTRASOUND MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL PAROXYSMAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL PAROXYSMAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL PAROXYSMAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL PERMANENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL PERMANENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL PERMANENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL PERSISTENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PERSISTENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PERSISTENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL LONG-STANDING PERSISTENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL LONG-STANDING PERSISTENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL LONG-STANDING PERSISTENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SHORT-TERM PERSISTENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SHORT-TERM PERSISTENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SHORT-TERM PERSISTENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL OPEN-HEART SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SPECIALTY CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 74. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 81. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 83. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 84. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 85. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 90. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 92. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 93. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 94. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 95. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 99. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 101. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 102. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 103. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 104. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 105. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 106. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 107. EUROPE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 110. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 111. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 112. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 113. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 114. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 119. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 120. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 121. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 122. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 123. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 124. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 125. AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 129. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 130. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 131. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 132. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 133. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 134. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 135. ASEAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 136. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 138. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 139. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 140. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 141. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 142. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 143. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 144. GCC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 150. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 151. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 152. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 153. EUROPEAN UNION ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 156. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 157. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 158. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 159. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 160. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 161. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 162. BRICS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 165. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 166. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 167. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 168. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 169. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 170. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 171. G7 ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 174. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 175. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 176. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 177. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 178. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 179. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 180. NATO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 182. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 183. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 184. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 185. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 186. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 187. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 188. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 189. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 190. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 191. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 192. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 193. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 194. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 195. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 196. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 197. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 198. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 199. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 201. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 202. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 203. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 204. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 205. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 206. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 207. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 208. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 210. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 211. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 212. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 213. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 214. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 215. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 216. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 217. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 219. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 220. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 221. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 222. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 223. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 224. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 225. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 226. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 229. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 230. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 231. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 232. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 233. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 234. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 235. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 238. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 239. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 240. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 241. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 242. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 243. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 244. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 247. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 248. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 249. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 250. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 251. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 252. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 253. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 256. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 257. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 258. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 259. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 260. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 261. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 262. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 265. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 266. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 267. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 268. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 269. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 270. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 271. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 274. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 275. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 276. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 277. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 278. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 279. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 280. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 283. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 284. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 285. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 286. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 287. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 288. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 289. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 292. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 293. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 294. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 295. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 296. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 297. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 298. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 301. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 302. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 303. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 304. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 305. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 306. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 307. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 310. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ENERGY SOURCE, 2017-2032 (USD MILLION)
TABLE 311. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY LASER, 2017-2032 (USD MILLION)
TABLE 312. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ULTRASOUND, 2017-2032 (USD MILLION)
TABLE 313. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2017-2032 (USD MILLION)
TABLE 314. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PERSISTENT, 2017-2032 (USD MILLION)
TABLE 315. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 316. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2025
TABLE 318. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Acutus Medical, Inc
  • Affera, Inc.
  • AFreeze GmbH
  • Atrian Medical Ltd.
  • AtriCure, Inc.
  • AuriGen Medical
  • BIOTRONIK SE & CO. KG
  • Boston Scientific Corporation
  • Cardiofocus, Inc.
  • CathRx Ltd
  • Cook Group Incorporated
  • F. Hoffmann-La Roche AG
  • GE HealthCare Technologies Inc.
  • Healium Medical
  • Japan Lifeline Co.
  • Johnson & Johnson Services, Inc.
  • Kardium Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Osypka AG
  • SentiAR, Inc
  • Siemens Healthcare GmbH
  • Stryker Corporation
  • Terumo Corporation
  • Toray Medical Co., Ltd.
  • Vanguard AG
  • Volta Medical

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.43 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.98 Billion
Compound Annual Growth Rate9.5%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Atrial Fibrillation Surgery Market - Global Strategic Business Report - Product Image

Atrial Fibrillation Surgery Market - Global Strategic Business Report

  • Report
  • 180 Pages
  • Global
From
Thoracic Surgery Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035) - Product Image

Thoracic Surgery Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

  • Report
  • 400 Pages
  • Global
From
Atherectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Atherectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Robotic Cardiac Surgery Market - Global Forecast 2025-2032 - Product Image

Robotic Cardiac Surgery Market - Global Forecast 2025-2032

  • Report
  • 189 Pages
  • Global
From
Focused Ultrasound Ablation Surgery Market - Global Forecast 2026-2032 - Product Image

Focused Ultrasound Ablation Surgery Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From

About the Atrial Fibrillation Surgery Market

Atrial Fibrillation Surgery is a type of surgical procedure used to treat a heart condition known as atrial fibrillation. This condition is characterized by an irregular heartbeat, which can lead to a variety of symptoms such as chest pain, shortness of breath, and fatigue. The goal of the surgery is to restore the heart's normal rhythm and reduce the risk of stroke. The most common type of atrial fibrillation surgery is the Maze procedure, which involves creating a series of small incisions in the heart to create a maze-like pattern. Other types of atrial fibrillation surgery include catheter ablation, cryoablation, and radiofrequency ablation. The Atrial Fibrillation Surgery market is composed of a variety of companies that provide products and services related to the diagnosis and treatment of atrial fibrillation. These companies include medical device manufacturers, healthcare providers, and research organizations. Examples of companies in the Atrial Fibrillation Surgery market include Medtronic, St. Jude Medical, Boston Scientific, and Biosense Webster. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.